Phase 3 Nasopharangeal Cancer Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:
Nasopharangeal Cancer
Jiangxi Provincial Cancer Hospital148 enrolled1 locationNCT07559877
Recruiting
Phase 3
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
Nasopharangeal CancerDistant Metastasis
Sun Yat-sen University260 enrolled5 locationsNCT07235319